Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17K Sell
151
-74
-33% -$6.53K 0.01% 1163
2025
Q4
$15K Sell
225
-164
-42% -$13.1K 0.01% 1387
2025
Q3
$32K Sell
389
-247
-39% -$17.8K 0.02% 1093
2025
Q2
$42K Sell
636
-1,501
-70% -$93.4K 0.02% 957
2025
Q1
$140K Buy
2,137
+689
+48% +$46.7K 0.09% 290
2024
Q4
$111K Sell
1,448
-168
-10% -$14.5K 0.07% 456
2024
Q3
$135K Buy
1,616
+1,613
+53,767% +$107K 0.08% 358
2024
Q2
$0 Hold
3
﹤0.01% 2175
2024
Q1
$0 Hold
3
﹤0.01% 2175
2023
Q4
$0 Hold
3
﹤0.01% 2075
2023
Q3
$0 Sell
3
-1
-25% -$34 ﹤0.01% 2042
2023
Q2
$0 Hold
4
﹤0.01% 2060
2023
Q1
$0 Buy
+4
New +$121 ﹤0.01% 1934

Other funds holding ACLX

Covestor's ACLX Position: Q1 2026 in Review

Covestor reduced its Arcellx (ACLX) stake by 33% in Q1 2026, selling an estimated $6.53K and leaving 151 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #1163.

Covestor first reported a position in ACLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $140K in Q1 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Covestor held 151 shares of Arcellx worth $17K as of Q1 2026.
  • Covestor sold 74 Arcellx shares in Q1 2026, an estimated $6.53K.
  • Arcellx made up 0.01% of Covestor's portfolio in Q1 2026, its #1163 holding.
  • Covestor first reported a position in Arcellx in Q1 2023 and has held it in 13 quarters since.
  • Covestor's Arcellx position peaked at $140K in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.